Biochemical Engineering Special Interest Group
biological engineering professionals
07 February 2017

Gammaplex 10% Gets FDA Approval

Bio Products Laboratory announced that the Food and Drug Administration (FDA) has approved Gammaplex 10% (immune globulin intravenous [human], 10% liquid) for the treatment of primary immunodeficiency (PI) and chronic immune thrombocytopenic purpura (ITP) in adults. Gammaplex 10% contains an immune globulin G (IgG) concentration of 100g/L and is stabilized with glycine. Source: 7/2/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).